Alnylam Pharmaceuticals, Inc. (ALNY)

327.09 -5.83 (-1.75%) USD  |  NASDAQ  |  Mar 02, 12:16
More

Alnylam Pharmaceuticals Earnings Loss from Eq. Investments (Quarterly)

Earnings Loss from Eq. Investments (Quarterly) Chart

View Earnings Loss from Eq. Investments (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Earnings Loss from Eq. Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years

View Earnings Loss from Eq. Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Earnings Loss from Eq. Investments (Quarterly) Benchmarks

View Earnings Loss from Eq. Investments (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Biogen, Inc. --
Pfizer Inc. --
Eli Lilly & Co. --
AbbVie, Inc. --